Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator.
CONCLUSION: Truxima® prevents poor outcomes of MPA and GPA as effectively as does Mabthera®.
PMID: 32734735 [PubMed - in process]
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Kwon HC, Kim MK, Song JJ, Park YB, Lee SW Tags: Yonsei Med J Source Type: research